---
schema_version: "secwatch.filing_event.v1"
accession: "0001867096-26-000091"
form_type: "8-K"
ticker: "XERS"
cik: "0001867096"
company_name: "Xeris Biopharma Holdings, Inc."
filed_at: "2026-10-14T11:08:18+00:00"
generated_at: "2026-10-14T11:10:03.814762+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Xeris sues Torrent, Rising Pharma and others over generic KEVEYIS after '502 patent grant

## Summary
- Xeris Pharmaceuticals filed two patent infringement suits Oct 13, 2026 in the U.S. District Court for the District of New Jersey over generic dichlorphenamide.
- Action 1 defendants: Torrent Pharma Inc., Torrent Pharmaceuticals Limited, Cycle Pharmaceuticals Limited, Lemed Pharmacy III LLC and Lemed Specialty Pharmacy Arizona LLC.
- Action 2 defendants: Rising Pharma Holdings, Inc. and Rising Pharma Specialties Pvt. Ltd.
- Suits follow grant of U.S. Patent No. 12,758,502 relating to Xeris' KEVEYIS (dichlorphenamide) product.
- Xeris seeks infringement judgment, injunctive relief, monetary and enhanced damages, attorneys' fees and costs.

## SEC filing metadata
- accession: 0001867096-26-000091
- form_type: 8-K
- ticker: XERS
- cik: 0001867096
- company_name: Xeris Biopharma Holdings, Inc.
- filed_at: 2026-10-14T11:08:18+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867096/000186709626000091/0001867096-26-000091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867096/000186709626000091/xers-20261013.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001867096-26-000091
- JSON: https://secwatch.observer/filing/0001867096-26-000091.json
- Plain text: https://secwatch.observer/filing/0001867096-26-000091.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.